Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?
Eric Ouvrard, Ashjan Kaseb, Nathan Poterszman, Clémence Porot, Francois Somme, Alessio Imperiale · 2024
Read Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine? by Eric Ouvrard, Ashjan Kaseb, Nathan Poterszman, Clémence Porot, Francois Somme, Alessio Imperiale (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10823373.txt.
Description
Eric Ouvrard and five co-authors review nuclear imaging for cancer spread to bone, in a study dated 2023 in the head of the text though the catalog lists 2024. Finding bone spread early, and judging whether treatment works, steers care and quality of life. The classic bone scan is widely used but blunt. Newer PET scans, paired with CT, sharpen both place and diagnosis with tracers tuned to each cancer.
The review weighs each method's strengths and traps across cancers of many origins. It stresses how tracer choice and reading pitfalls shape what a bright spot means. The authors frame the newer scans as the tools of personalized care for bone disease.
Catalog record
| CREATOR | Eric Ouvrard, Ashjan Kaseb, Nathan Poterszman, Clémence Porot, Francois Somme, Alessio Imperiale |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |